Accordingly, the expression of XBP1 in CD11c+ DCs was reported to be critical for the initiation and progression of ovarian cancer, and its conditional ablation in DCs in the tumour microenvironment enhanced the capacity to restrict tumour growth. This evidence concerns the gene ITGAX and neoplasm.